subscribe
 

New pooled donor suspension hepatocytes

Lonza’s new pooled donor suspension hepatocytes enable the next level of reliability, robustness and customisability



Automated solution for endotoxin detection

Lonza set to unveil a fully automated plate-based robotic solution for high precision in endotoxin detection



New electronic batch record execution platform

Lonza to reveal next-generation electronic batch record execution platform at Cell and Gene Therapy Manufacturing Forum 2018



Construction of a skin model using R3D cell culture system

Lonza releases new technical note: "Construction of a full-thickness skin model using RAFT 3D cell culture system"



Next-generation of endotoxin detection solution

First glimpse of new endotoxin automation product offered at PDA 2018 event



Cell-culture portfolio expands

Lonza adds Quasi Vivo System to its portfolio



Latest research in ADME-Tox models to be presented

Lonza to present research into more physiologically relevant ADME-Tox models at the Society of Toxicology Meeting



New offering for drug metabolism studies

Lonza announces new offering of Silensomes HLM for drug metabolism studies



Distribution deal for cell culture system

Lonza to expand the availability of the RAFT 3D Cell Culture System via agreement with TAP Biosystems



Identifying genes in lung fibroblasts

Ludger Altrogge, Lubna Hussain and Rochelle Myers report on asthma- and COPD-related differential gene expression in primary human lung fibroblasts



HUVEC product line expanded

Improved version with faster proliferation rates than traditional HUVECs in EGM Growth Media



New services for rational vaccine development

Lonza aims to help reduce the cost of failure and increase the chance of clinical success



Lonza launches 2013-2014 BioResearch Catalog

Diabetes prevention has become a key focus area for the drug development market.



PAT software solution agreement

Lonza and Camo Software have entered into an agreement on a PAT software solution



Fighting Influenza A (H7N9) Virus

Human infections with H7N9 flu first emerged in China in March 2013 and since then, China has reported cases of human H7N9 infection to the The World Health Organization (WHO). Human infections with other subgroups of H7 influenza viruses (H7N2, H7N3 and H7N7) have previously been reported in the Netherlands, Italy, Canada, United States of America, Mexico and the United Kingdom.




Stem cell solutions showcased at ISSCR event

ISSCR show preview from stem cell research specialist



Keep up to speed with Lonza’s free Resource Notes™ journal

With the slogan “Science Doesn't Slow Down, and Neither Should You”, Lonza invites its customers to subscribe to the company’s free scientific journal. Resource Notes™ provides updates on the latest scientific developments and research tools from Lonza.



Join Lonza’s free webinar on convenient and efficient non-viral iPSC generation

The first webinar is scheduled for 18 June 2013 at 10 AM CEST (Berlin). The second session will be held on 19 June 2013 at 2 PM EDT (New York).



Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe